Re-evaluation of the metabolism of carbocisteine in a British white population.

doi:10.1097/00008571-199310000-00007

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Re-evaluation of the metabolism of carbocisteine in a British white population.

Pharmacogenetics - 1 Oct 1993

Gregory W L, James O F, Turner I, Meese C O, Idle J R

Abstract excerpt

It has been claimed that the amino acid derivative carbocisteine is predominantly metabolized by sulfoxidation and that this pathway exhibits a genetic polymorphism. Moreover, those subjects with a 'poor metabolizer' phenotype have been thought to have a genetic predisposition to developing certain diseases. We have confirmed the observations of others that this marker drug does not undergo significant...

Topics

Adult
Aged
Aged, 80 and over
Biotransformation
Carbocysteine
Female
Humans
Male
Middle Aged
Phenotype
Polymorphism, Genetic
United Kingdom
White People

Source

Open in PubMed

Identifiers

PMID: 8287066
DOI: 10.1097/00008571-199310000-00007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics